ABSI Absci Corporation Common Stock Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All Content
Source feeds
Buzzberg's Top 50
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
16:18
May 06
Holding spot ABSI after taking 268% profit on calls; sees it running to ~$9 on insider open-market buying.
ABSI
HIGH
17:53
May 04
Holds ABSI calls up 200% — bullish, 'there's always a bull market somewhere'.
ABSI
MED
01:51
May 01
Holds ABSI calls up 185% in 2 weeks; conviction from insider buys by ex-Philips CEO and ex-AstraZeneca EVP.
ABSI
HIGH
15:32
Apr 27
Holds ABSI calls bought at $3.15, now up 105% — 'there's always a bull market somewhere'.
ABSI
MED
10:22
Apr 19
Likes Absci; accommodating FDA + AI-augmented biotech R&D thesis, accumulate equity pullbacks.
ABSI
MED
17:38
Apr 17
Names Absci as a current pick (AI-biotech / FDA thesis restated from prior posts).
ABSI
LOW
03:20
Apr 17
Bull case for Absci: AI proliferating oncology/therapeutics; highlights ABSI funded through 2028 as de-risking the long.
ABSI 1ST
MED

About ABSI Analyst Coverage

Buzzberg tracks ABSI (Absci Corporation Common Stock) across 1 sources. 7 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 7 total trade ideas tracked.